Scientists Reverse Cell Age Below 20

In a significant laboratory advancement, cells from an 80-year-old donor were rejuvenated to a molecular age below 20, as measured by epigenetic clocks. This was achieved by directly converting them into induced neural stem cells, a process that notably skipped the typical pluripotent intermediate stage. This unique method has provided researchers with an unprecedented opportunity to study the molecular shifts associated with aging across a cell's transition.

The research, conducted by scientists at the University of Bonn and University Hospital Bonn, was published in Aging Cell in 2026. The process of rejuvenation took place over several months, with key epigenetic changes observed over approximately 50 days. This extended timeline allows for detailed tracking of factors influencing aging and provides a potential window for testing compounds.

While the findings are scientifically important, they are confined to cultured cells and do not demonstrate clinical rejuvenation in humans. The resulting neural stem cells can generate neurons, offering a donor-derived laboratory model for studying age-related neurological diseases. This breakthrough offers a precise research instrument for conditions like Alzheimer's, enabling controlled comparisons of aging processes.